NOVOLINPEN DIAL-A-DOSE INSULIN DELIVERY DEVICE

NOVOLINPEN DIAL-A-DOSE INSULIN DELIVERY DEVICE is an FDA 510(k)-cleared medical device (K921908) manufactured by Novo Nordisk Pharmaceuticals, Inc.. This device is classified under the General Hospital specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on June 28, 1993. Regulation: 8.